Pilot Study Finds 30-Day Molecular Improvement in Prostate Health Following Intraprostatic Ozone Therapy, Tracked by the EpiSwitch® PSE Blood Test

Doctors Studio by Forum Health, LLC today announced pilot findings indicating that intraprostatic ozone therapy was ...
Business Wire

Oxford BioDynamics’ Prostate Screening EpiSwitch® Blood Test Significantly Enhances Overall Detection Accuracy For At Risk Men

Prostate Screening EpiSwitch (PSE) blood test shows significant potential as an accurate and rapid cancer screening diagnostic High accuracy (94%), PPV (92%), and NPV (94%) reported in the high-impact ...
EurekAlert!

The new prostate cancer blood test with 94 per cent accuracy

Researchers at the University of East Anglia have helped develop a new blood test to detect prostate cancer with greater accuracy than current methods. New research shows that the Prostate Screening ...
News Medical

New blood test can detect prostate cancer with greater accuracy than current methods

Researchers at the University of East Anglia have helped develop a new blood test to detect prostate cancer with greater accuracy than current methods. New research shows that the Prostate Screening ...
BioWorld

Oxford Biodynamics launches test for more accurate prostate screening

The receipt of a reimbursement code for the Episwitch Prostate Screening (PSE) test developed by Oxford Biodynamics plc, following its recent launch, is good news for men frustrated with the ...

Oxford BioDynamics enters Romanian market with Regina Maria

OXFORD, UK - Oxford BioDynamics Plc (AIM: OBD), a biotechnology company specializing in precision clinical diagnostics, has partnered with Regina Maria, Romania's leading private healthcare provider, ...